Please enable JavaScript to continue using this application.

Compare $INDP vs $IRD | Chartloom

Compare

$INDP vs $IRD

Indaptus Therapeutics Inc · Opus Genetics Inc

INDP

Indaptus Therapeutics Inc

IRD

Opus Genetics Inc

Compare $INDP vs $IRD

Comparing Indaptus Therapeutics Inc and Opus Genetics Inc

INDPIndaptus Therapeutics Inc

IRDOpus Genetics Inc

INDPIndaptus Therapeutics Inc

Market cap

$284M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-8.4%

52W performance

-42.7%

FCF yield

-5.2%

IRDOpus Genetics Inc

Market cap

$384M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

28.68x

Rev growth (TTM)

-36.1%

YTD performance

119.3%

52W performance

126.8%

FCF yield

-10.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INDP

IRD

Detailed metrics comparison

INDP

Indaptus Therapeutics Inc

IRD

Opus Genetics Inc

Market Cap

INDP$284M

IRD$384M

Enterprise Value

INDP$277M

IRD$331M

Price

INDP$2.51

IRD$4.65

P/E Ratio

INDPN/A

IRDN/A

P/S Ratio

INDP0.00x

IRD38.96x

EV/Sales

INDP0.00x

IRD33.62x

EV/EBITDA

INDP0.00x

IRD11.29x

P/B Ratio

INDP32.14x

IRD24.83x

P/FCF Ratio

INDPN/A

IRDN/A

EV/FCF

INDP-18.83x

IRD-8.15x

PEG Ratio

INDPN/A

IRDN/A

Forward P/E (NTM)

INDPN/A

IRDN/A

Forward P/S (NTM)

INDPN/A

IRD28.68x

Revenue (TTM)

INDP$0

IRD$10M

Revenue Growth (YoY)

INDPN/A

IRD-36.1%

Forward Rev Growth

INDP0.0%

IRD8.5%

Gross Margin (TTM)

INDP0.0%

IRD0.0%

Operating Margin (TTM)

INDP0.0%

IRD0.0%

EBITDA Margin (TTM)

INDP0.0%

IRD-504.8%

Net Margin (TTM)

INDP0.0%

IRD-1091.8%

FCF Margin (TTM)

INDPN/A

IRD-412.6%

Net Income (TTM)

INDP$-15M

IRD$-108M

FCF (TTM)

INDP$-15M

IRD$-41M

EPS (TTM)

INDP-$0.13

IRD-$1.13

ROE (TTM)

INDP-30275.0%

IRD-31635.0%

ROA (TTM)

INDP-20348.0%

IRD-17489.0%

ROIC (TTM)

INDP-30275.0%

IRD-30100.0%

Cash

INDP$8M

IRD$89M

Debt

INDP$0

IRD$36M

Net Cash/Debt

INDP$8M

IRD$53M

Current Ratio (TTM)

INDP19.48x

IRD12.19x

Quick Ratio (TTM)

INDP18.82x

IRD11.87x

Debt/Equity (TTM)

INDP0.00x

IRD0.07x

Debt/Assets (TTM)

INDP0.0%

IRD0.0%

Interest Coverage (TTM)

INDPN/A

IRDN/A

Net Debt/EBITDA (TTM)

INDP0.00x

IRD0.00x

Beta

INDP0.99

IRD0.77

52W Performance

INDP-42.7%

IRD126.8%

YTD Performance

INDP-8.4%

IRD119.3%

% from 52W High

INDP-57.9%

IRD-34.2%

% from 52W Low

INDP172.8%

IRD173.5%

Asset Turnover (TTM)

INDP0.00x

IRD0.16x

FCF Yield (TTM)

INDP-5.2%

IRD-10.6%

Earnings Yield (TTM)

INDP-5.4%

IRD-28.0%

Dividend Yield (TTM)

INDPN/A

IRDN/A

Rule of 40

INDP0.0

IRD-448.7

EV/GP/RG

INDPN/A

IRDN/A

Ticker research

View INDP research View IRD research

Metric	INDP Indaptus Therapeutics Inc	IRD Opus Genetics Inc
Market & Valuation
Market Cap	$284M	$384M
Enterprise Value	$277M	$331M
Price	$2.51	$4.65
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	38.96x
EV/Sales	0.00x	33.62x
EV/EBITDA	0.00x	11.29x
P/B Ratio	32.14x	24.83x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.83x	-8.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	28.68x
Revenue & Growth
Revenue (TTM)	$0	$10M
Revenue Growth (YoY)	N/A	-36.1%
Forward Rev Growth	0.0%	8.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-504.8%
Net Margin (TTM)	0.0%	-1091.8%
FCF Margin (TTM)	N/A	-412.6%
Net Income (TTM)	$-15M	$-108M
FCF (TTM)	$-15M	$-41M
EPS (TTM)	-$0.13	-$1.13
ROE (TTM)	-30275.0%	-31635.0%
ROA (TTM)	-20348.0%	-17489.0%
ROIC (TTM)	-30275.0%	-30100.0%
Financial Health
Cash	$8M	$89M
Debt	$0	$36M
Net Cash/Debt	$8M	$53M
Current Ratio (TTM)	19.48x	12.19x
Quick Ratio (TTM)	18.82x	11.87x
Debt/Equity (TTM)	0.00x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	0.77
52W Performance	-42.7%	126.8%
YTD Performance	-8.4%	119.3%
% from 52W High	-57.9%	-34.2%
% from 52W Low	172.8%	173.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.16x
FCF Yield (TTM)	-5.2%	-10.6%
Earnings Yield (TTM)	-5.4%	-28.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-448.7
EV/GP/RG	N/A	N/A
Ticker research	View INDP research	View IRD research

Valuation

P/S Ratio

INDP

0.00x

IRD

38.96x

EV/FCF

INDP

-18.83x

IRD

-8.15x

Growth & revenue

Revenue Growth TTM

IRD

-36.1%

Forward Revenue Growth

IRD

8.5%

INDP

0.0%

Profitability & performance

Gross Margin

INDP

0.0%

IRD

0.0%

ROE

INDP

-30275.0%

IRD

-31635.0%

FCF Yield %

INDP

-5.2%

IRD

-10.6%

52-Week Performance

IRD

126.8%

INDP

-42.7%

Detailed metrics comparison

INDP

Indaptus Therapeutics Inc

IRD

Opus Genetics Inc

Market Cap

INDP$284M

IRD$384M

Enterprise Value

INDP$277M

IRD$331M

Price

INDP$2.51

IRD$4.65

P/E Ratio

INDPN/A

IRDN/A

P/S Ratio

INDP0.00x

IRD38.96x

EV/Sales

INDP0.00x

IRD33.62x

EV/EBITDA

INDP0.00x

IRD11.29x

P/B Ratio

INDP32.14x

IRD24.83x

P/FCF Ratio

INDPN/A

IRDN/A

EV/FCF

INDP-18.83x

IRD-8.15x

PEG Ratio

INDPN/A

IRDN/A

Forward P/E (NTM)

INDPN/A

IRDN/A

Forward P/S (NTM)

INDPN/A

IRD28.68x

Revenue (TTM)

INDP$0

IRD$10M

Revenue Growth (YoY)

INDPN/A

IRD-36.1%

Forward Rev Growth

INDP0.0%

IRD8.5%

Gross Margin (TTM)

INDP0.0%

IRD0.0%

Operating Margin (TTM)

INDP0.0%

IRD0.0%

EBITDA Margin (TTM)

INDP0.0%

IRD-504.8%

Net Margin (TTM)

INDP0.0%

IRD-1091.8%

FCF Margin (TTM)

INDPN/A

IRD-412.6%

Net Income (TTM)

INDP$-15M

IRD$-108M

FCF (TTM)

INDP$-15M

IRD$-41M

EPS (TTM)

INDP-$0.13

IRD-$1.13

ROE (TTM)

INDP-30275.0%

IRD-31635.0%

ROA (TTM)

INDP-20348.0%

IRD-17489.0%

ROIC (TTM)

INDP-30275.0%

IRD-30100.0%

Cash

INDP$8M

IRD$89M

Debt

INDP$0

IRD$36M

Net Cash/Debt

INDP$8M

IRD$53M

Current Ratio (TTM)

INDP19.48x

IRD12.19x

Quick Ratio (TTM)

INDP18.82x

IRD11.87x

Debt/Equity (TTM)

INDP0.00x

IRD0.07x

Debt/Assets (TTM)

INDP0.0%

IRD0.0%

Interest Coverage (TTM)

INDPN/A

IRDN/A

Net Debt/EBITDA (TTM)

INDP0.00x

IRD0.00x

Beta

INDP0.99

IRD0.77

52W Performance

INDP-42.7%

IRD126.8%

YTD Performance

INDP-8.4%

IRD119.3%

% from 52W High

INDP-57.9%

IRD-34.2%

% from 52W Low

INDP172.8%

IRD173.5%

Asset Turnover (TTM)

INDP0.00x

IRD0.16x

FCF Yield (TTM)

INDP-5.2%

IRD-10.6%

Earnings Yield (TTM)

INDP-5.4%

IRD-28.0%

Dividend Yield (TTM)

INDPN/A

IRDN/A

Rule of 40

INDP0.0

IRD-448.7

EV/GP/RG

INDPN/A

IRDN/A

Ticker research

View INDP research View IRD research

Metric	INDP Indaptus Therapeutics Inc	IRD Opus Genetics Inc
Market & Valuation
Market Cap	$284M	$384M
Enterprise Value	$277M	$331M
Price	$2.51	$4.65
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	38.96x
EV/Sales	0.00x	33.62x
EV/EBITDA	0.00x	11.29x
P/B Ratio	32.14x	24.83x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.83x	-8.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	28.68x
Revenue & Growth
Revenue (TTM)	$0	$10M
Revenue Growth (YoY)	N/A	-36.1%
Forward Rev Growth	0.0%	8.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-504.8%
Net Margin (TTM)	0.0%	-1091.8%
FCF Margin (TTM)	N/A	-412.6%
Net Income (TTM)	$-15M	$-108M
FCF (TTM)	$-15M	$-41M
EPS (TTM)	-$0.13	-$1.13
ROE (TTM)	-30275.0%	-31635.0%
ROA (TTM)	-20348.0%	-17489.0%
ROIC (TTM)	-30275.0%	-30100.0%
Financial Health
Cash	$8M	$89M
Debt	$0	$36M
Net Cash/Debt	$8M	$53M
Current Ratio (TTM)	19.48x	12.19x
Quick Ratio (TTM)	18.82x	11.87x
Debt/Equity (TTM)	0.00x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	0.77
52W Performance	-42.7%	126.8%
YTD Performance	-8.4%	119.3%
% from 52W High	-57.9%	-34.2%
% from 52W Low	172.8%	173.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.16x
FCF Yield (TTM)	-5.2%	-10.6%
Earnings Yield (TTM)	-5.4%	-28.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-448.7
EV/GP/RG	N/A	N/A
Ticker research	View INDP research	View IRD research